raloxifene hydrochloride has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callier, S; Di Paolo, T; Grandbois, M; Morissette, M | 1 |
1 other study(ies) available for raloxifene hydrochloride and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice.
Topics: Animals; Dopamine; Dopamine Agents; Drug Evaluation, Preclinical; Estrogens; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stereoisomerism | 2000 |